190 related articles for article (PubMed ID: 6361798)
1. Inotropic agents in the treatment of cardiogenic shock.
Bourdarias JP; Dubourg O; Gueret P; Ferrier A; Bardet J
Pharmacol Ther; 1983; 22(1):53-79. PubMed ID: 6361798
[No Abstract] [Full Text] [Related]
2. Cardiogenic shock. Recent advances in pharmacologic management. II.
Kones RJ
N Y State J Med; 1973 Aug; 73(15):1967-80. PubMed ID: 4354585
[No Abstract] [Full Text] [Related]
3. Inotropic agents in the treatment of cardiogenic shock.
Mueller HS
World J Surg; 1985 Feb; 9(1):3-10. PubMed ID: 3885584
[No Abstract] [Full Text] [Related]
4. Drug therapy in cardiogenic shock.
Ramdohr B
Int J Clin Pharmacol; 1973 Apr; 7(2):118-26. PubMed ID: 4731279
[No Abstract] [Full Text] [Related]
5. [Dobutamine, dopamine, and other catecholamine-like substances for myocardial infarct].
Machii K
Nihon Rinsho; 1983 Dec; 41(12):2685-90. PubMed ID: 6674555
[No Abstract] [Full Text] [Related]
6. Use of drugs in cardiogenic shock due to acute myocardial infarction.
Gunnar RM; Loeb HS
Circulation; 1972 May; 45(5):1111-24. PubMed ID: 4553612
[No Abstract] [Full Text] [Related]
7. Use of catecholamines in acute myocardial infarction.
Dixon DW; Loeb HS; Gunnar RM
Herz; 1979 Oct; 4(5):385-96. PubMed ID: 391685
[TBL] [Abstract][Full Text] [Related]
8. Cardiogenic shock and its current treatment.
Willerson JT
Tex Med; 1975 Apr; 71(4):49-59. PubMed ID: 1135757
[No Abstract] [Full Text] [Related]
9. [Cardiogenic shock. Therapy].
Pop T; Erbel R; Henrichs KJ; Esser MJ; Meyer J
Dtsch Med Wochenschr; 1986 Jul; 111(28-29):1118-20. PubMed ID: 3089754
[No Abstract] [Full Text] [Related]
10. Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy.
Takkunen J; Oilinki O; Huhti E; Vuopala U; Koivisto O
Acta Med Scand; 1972 Sep; 192(3):165-70. PubMed ID: 5055261
[No Abstract] [Full Text] [Related]
11. Clinical use of inotropic agents.
Spores J; DeWood MA
AANA J; 1979 Dec; 47(6):679-84. PubMed ID: 525231
[No Abstract] [Full Text] [Related]
12. Acute circulatory failure secondary to myocardial infarction.
McCann WD; O'Donovan TP
Postgrad Med; 1971 May; 49(5):74-9. PubMed ID: 4325238
[No Abstract] [Full Text] [Related]
13. Cardiogenic shock: therapeutic implications of altered myocardial energy balance.
Kones RJ
Angiology; 1974 May; 25(5):317-33. PubMed ID: 4150913
[No Abstract] [Full Text] [Related]
14. The failing myocardium. I. Drug management.
Loeb HS; Rahimtoola SH; Gunnar RM
Med Clin North Am; 1973 Jan; 57(1):167-85. PubMed ID: 4143986
[No Abstract] [Full Text] [Related]
15. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
El Mokhtari NE; Arlt A; Meissner A; Lins M
Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic support in cardiogenic shock.
Rude RE
Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
[TBL] [Abstract][Full Text] [Related]
17. [Catecholamines in the therapy of chronic cardiac insufficiency].
Brandt D; Klein W
Wien Med Wochenschr; 1982 Oct; 132(19):450-6. PubMed ID: 6294999
[No Abstract] [Full Text] [Related]
18. Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support.
Schreiber W; Herkner H; Koreny M; Bur A; Hirschl MM; Glogar D; Huber K; Laggner AN
Resuscitation; 2002 Dec; 55(3):269-76. PubMed ID: 12458064
[TBL] [Abstract][Full Text] [Related]
19. The patient in shock. I.
MacLean LD; Duff JH; McLean AP
Can Med Assoc J; 1971 Jul; 105(1):78-83. PubMed ID: 4932545
[No Abstract] [Full Text] [Related]
20. Management of shock in acute myocardial infarction.
Pema PJ
J Am Osteopath Assoc; 1971 Mar; 70(7):692-702. PubMed ID: 4926966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
